Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.

Launched by NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS · Aug 7, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how often a special heart monitoring device can detect a condition called atrial fibrillation (AF) in people who have had an acute ischemic stroke, which is a type of stroke caused by a blockage in blood flow to the brain. The researchers want to see if finding AF with this device can help doctors start blood-thinning medication sooner and reduce the chances of having another stroke.

To participate in this study, individuals must be 40 years or older and have recently experienced an acute ischemic stroke or a related condition called a transient ischemic attack (TIA). Participants will be closely monitored using the heart device and will need to give their consent to join the study. This trial is currently recruiting participants and aims to provide valuable insights into the connection between atrial fibrillation and stroke management.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled.
• • Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation \[brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan\].
• • Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study.
• • Informed consent for participation in the study will be obtained from the patients or guardians of patients.
• Exclusion Criteria:
• • Patients with incomplete evaluation will be excluded, as previously described. \[22\] -Patients with known or newly detected AF at hospitalization will also be excluded.
• • Not providing informed consent.